Veradigm | MDRX - Interest Expense On Debt


Veradigm reported $1.25M in Interest Expense on Debt for its fiscal quarter ending in September of 2022.





Interest Expense On Debt Change Date
Alcidion AUD 32K 9K Dec/2025
Ambu A/S DKK 24M 5M Jun/2026
Amplifon EUR 13.87M 155K Mar/2026
Cardinal Health USD 79M 22M Jun/2026
Centene USD 153M 11M Jun/2026
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Cigna USD 157.08B 3.82B Jun/2026
Coloplast 164M 0 Dec/2025
CVS Health USD 757M 17M Jun/2026
Diasorin EUR 5M 0 Mar/2026
Elevance Health USD 358M 6M Sep/2026
General Electric Aerospace USD 231M 265M Sep/2026
Gulf Medical Proj AED 33K 9K Sep/2024
Humana USD 197M 4M Jun/2026
IQVIA Holdings USD 197M 5M Jun/2026
Laboratory Of America USD 61.1M 6M Jun/2026
Maximus USD 23.88M 1.77M Jun/2026
McKesson USD 77M 18M Jun/2026
Med Life RON 24.78M 2.15M Dec/2023
Molina Healthcare USD 53M 1000K Sep/2026
Omnicell USD 431K 91K Dec/2025
Oriola-kd EUR 1.4M 600K Mar/2026
Owens Minor USD 27.93M 1.1M Dec/2025
Quest Diagnostics USD 61M 8M Sep/2026
Rede D'or Sao Luiz BRL 1.5B 2.05B Dec/2025
Siemens Healthineers EUR 100M 4M Mar/2026
Sonova Holding CHF 24.2M 3.7M Jun/2025
Supermax Corporation Bhd MYR 1.66M 1.44M Sep/2025
UnitedHealth USD 963M 1000K Sep/2026
Veeva Systems USD 74.42M 9.32M Mar/2026
Veradigm USD 1.25M 641K Sep/2022
Xerox USD 31M 0 Dec/2024